305 Unravelling the role of CD4+ and CD8+ T cells in pembrolizumab induced mycobacterium tuberculosis granuloma formation in nasopharyngeal carcinoma

BackgroundNasopharyngeal carcinoma (NPC), an endemic disease in Southeast Asia, is characterized by high immune cell infiltration. Pembrolizumab, an immune checkpoint inhibitor that blocks the programmed death-1 (PD-1) surface protein on CD4+ and CD8+ T cells and reactivate tumor autoimmunity,1 has...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal for immunotherapy of cancer 2021-11, Vol.9 (Suppl 2), p.A328-A329
Hauptverfasser: Desmond Hung, Tae Yang, Kam, Ngar Woon, Fun Lee, Victor Ho
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:BackgroundNasopharyngeal carcinoma (NPC), an endemic disease in Southeast Asia, is characterized by high immune cell infiltration. Pembrolizumab, an immune checkpoint inhibitor that blocks the programmed death-1 (PD-1) surface protein on CD4+ and CD8+ T cells and reactivate tumor autoimmunity,1 has shown promising results in early NPC trials.2 Despite the encouraging results, pembrolizumab induced mycobacterium tuberculosis (MTB) activation/reactivation cases have been reported.3 CD4+ T cells play a crucial role initiating MTB granuloma formation through releasing interferon gamma (IFNγ), and the CD4+PD1+ subtype is known to be crucial for controlling MTB infection.3 4 Indeed, CD8+ T cells are believed to play a less important role in MTB immunity. However, the mechanism of pembrolizumab induced MTB granuloma formation remains poorly understood, and the current study objective is to decipher the enigma through investigating the PD-1 and IFNγ expression of CD4+ and CD8+ T cells.MethodsWe encountered two NPC patients who suffered from pembrolizumab induced MTB granuloma formation, and their biopsy samples were collected and separated into three groups, malignant, non-malignant and granuloma. The samples were stained with the Opal multiplex immunohistochemistry kit (figure1).ResultsThe non-malignant group had the highest of amount of PD-1+CD8+ (188.3 cells/mm2), and the cell density was significantly higher than the malignant group (2.3 cells/mm2, p= 0.035) and the granuloma group (9 cells/mm2, p=0.017) (figure 2). Meanwhile, the IFNγ+CD8+ cell density of the granuloma group was the highest (91.5 cells/mm2), which was higher than the non-malignant group (19.3 cells/mm2, p=0.020) and the malignant group (56 cells/mm2/ p= 0.320) (figure 3). The cell density of PD-1+CD4+ was the highest in the non-malignant group (245 cells/mm2), which was also higher than the malignant group (10.7 cells/mm2, p=0.174) and the granuloma group (35.5 cells/mm2, p=0.155) (figure 4). Similarly, the cell density of IFNγ+CD4+ (96.5 cells/mm2) was the highest in granuloma group, which was higher than the malignant group (26.7 cells/mm2, p=0.550) and non-malignant group (15.22 cells/mm2, p=0.124) (figure 5).Abstract 305 Figure 1Multiplex Staining. Staining were performed using Opal multiplex immunohistochemistry staining kitAbstract 305 Figure 2Abstract 305 Figure 3Abstract 305 Figure 4Abstract 305 Figure 5ConclusionsCD8+ cells displayed more significant PD-1 downregulation and IFNγ upre
ISSN:2051-1426
2051-1426
DOI:10.1136/jitc-2021-SITC2021.305